Modular Medical (MODD) Proxy filing summary

Executive summary

• Annual Meeting scheduled for February 28, 2025, to be held virtually, with shareholders voting on key proposals including director elections, equity plan amendment, and auditor ratification.

• Shareholders of record as of January 17, 2025, are entitled to vote; 40,665,220 shares outstanding among approximately 66 holders.

• Proxy materials and annual report are available online; voting can be done via Internet, phone, mail, or during the virtual meeting.

Voting matters and shareholder proposals

• Election of seven directors to serve until the next annual meeting.

• Approval sought for an amendment to the 2017 Equity Incentive Plan to add 3,000,000 shares for issuance.

• Ratification of Farber Hass Hurley LLP as independent auditor for fiscal year ending March 31, 2025.

• Board recommends voting FOR all proposals.

Board of directors and corporate governance

• Board consists of seven nominees with diverse backgrounds in medical devices, finance, and healthcare.

• All board committees (Audit, Compensation, Nominating and Governance) are composed solely of independent directors.

• Board leadership structure separates chairman and CEO roles since August 2021.

• Board and committees held regular meetings, with high attendance and compliance with governance standards.